Hormone Therapy for Prostate Cancer Glens Falls NY

Hormone therapy to treat advanced prostate cancer can increase the risk of heart disease, but some types of hormone therapy appear to be safer than others, new research has found. The study included 30,642 Swedish men with either locally advanced prostate cancer or prostate cancer that had spread (metastatic cancer), who had received hormone therapy as primary treatment for their cancer.

Local Companies

HARRY SLATCH, MD
(518) 798-1719
102 Park Street
Glens Falls, NY
SAMUEL GOTTESMAN, MD
(518) 793-5142
90 South Street
Glens Falls, NY
Gordon Michael Ortiz, MD
518-583-0111
19 West Ave
Saratoga Springs, NY
Charles Irving Schwartz, MD
518-583-0111
19 West Ave Ste 103
Saratoga Springs, NY
Vincent Theodore Cooper, MD
518-798-1719
102 Park St Ste 201
Glens Falls, NY
PETER HUGHES, MD
(518) 792-5340
526 Glen Street
Glens Falls, NY
RAYMOND MADDOCKS, MD
(518) 798-1719
102 Park Street
Glens Falls, NY
RUSTOM RASTINEHAD, MD
(518) 587-8421
271 W Circular Street
Saratoga Springs, NY
Rustom A Rastinehad, MD
518-587-8421
271 W Circular St
Saratoga Springs, NY
Harry Slatch, MD
518-798-1719
102 Park St Ste 201
Glens Falls, NY
Data Provided by:
  

Provided By:

TUESDAY, Sept. 22 (HealthDay News) -- Hormone therapy to treat advanced prostate cancer can increase the risk of heart disease, but some types of hormone therapy appear to be safer than others, new research has found.

The study included 30,642 Swedish men with either locally advanced prostate cancer or prostate cancer that had spread (metastatic cancer), who had received hormone therapy as primary treatment for their cancer.

The study findings were scheduled to be presented Tuesday at the European Cancer Organization meeting in Berlin.

In a news release from the European Cancer Organization, the researchers described the types of hormone therapy used: removal of the testicles to eliminate the main source of testosterone production; injections of gonadotropin-releasing hormone agonists to reduce testosterone production by the testicles; and anti-androgen pills that block testosterone from attaching to prostate cells. Most of the patients received one treatment, but 38 percent were given two types of drugs, the study authors noted.

The men were followed for an average of three years and monitored for ischemic heart disease, heart attacks, arrhythmia, and heart failure.

"We found that prostate cancer patients treated with hormone therapy had an elevated risk of developing all of the individual types of heart problems and that they were more likely than normal to die from those causes," study lead author Mieke Van Hemelrijck, a cancer epidemiologist at King's College in London, England, said in the news release.

Specifically, hormone therapy was associated with a 24 percent increased risk of heart attack, a 19 percent increased risk of arrhythmia, a 31 percent increased risk of ischemic heart disease, and a 26 percent increased risk of heart failure, the researchers found. The increased risk of heart disease began a few months after the men began hormone therapy.

The study also found that hormone therapy was associated with a 28 percent increased risk of fatal heart attack, a 21 percent increased risk of dying from heart disease, a 26 percent increased risk of death from heart failure, and a 5 percent increased risk of fatal arrhythmia.

"In a more detailed analysis by type of hormone therapy, the lowest increase in risk for ischemic heart disease, heart attack and heart failure was seen in the group taking anti-androgen therapy, and we saw no increase in risk of death from heart disease in this group. Patients on gonadotropin-releasing hormone agonist therapy had the highest risk of these problems," Van Hemelrijck said.

The findings suggest that physicians should consider heart-related side effects when prescribing hormone therapy for prostate cancer patients and may want to refer patients to a cardiologist before the start of hormone therapy, the researchers stated.

More information

The American Urological Association Foundation has more about hormone therapy for prostate cancer.

SOURCE: European Cancer Organization, news release, Sept. 22, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com

Related Articles
- Diagnosis of Prostate Cancer Glens Falls NY
Mass screening for prostate cancer with a test for prostate-specific antigen (PSA) has led to mass over-diagnosis and over-treatment, a new study contends. Since the PSA screening test came into use in 1986, federal government data show that the number of prostate cancer cases in the United States has risen substantially, said the report in the Aug. 31 online issue of the Journal of the National Cancer Institute.
- Hormone Therapy for Breast Cancer Glens Falls NY
- Menopausal Hormone Therapy Glens Falls NY
- Hormone Therapy Glens Falls NY
- Delayed Prostate Cancer Therapy Glens Falls NY
- Hormone Therapy for Lung Cancer Glens Falls NY
- Head and Neck Cancer Treatment Glens Falls NY
- Hormone Therapy for Early Prostate Cancer Glens Falls NY
- Exercise for Prostate Cancer Glens Falls NY
- Open Prostatectomy Versus Laparoscopic Procedure Glens Falls NY